Close Menu

NEW YORK (GenomeWeb) – PerkinElmer announced after the close of the market on Thursday that its fourth quarter revenues rose 18 percent year over year.

For the three months ended Dec. 30, 2018, the company posted revenues of $756.3 million compared to $641.6 million a year ago. It beat the consensus Wall Street estimate of $746.6 million.

Core organic revenue growth was 7 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study catalogues the genome and evolutionary history of the oak family, UPI reports.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.